TTS GROUP LIMITED
Location
Founded
1985-01-01
Website
Risk Signals
82 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Furniture, Schools and Educational Services, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about TTS GROUP LIMITED
Live alerts from global media, monitored by Business Radar
2024-05-10 (thehindu.com)
‘We need to stop the fear mongering on vaccines’
COVID-19 vaccine misinformation, TTS risk, and benefits explained by Dr. Anurag Agrawal, urging informed vaccination decisions.
Read more
2024-05-10 (thehindu.com)
‘We need to stop the fear mongering on vaccines’
COVID-19 vaccine misinformation, TTS risk, and benefits explained by Dr. Anurag Agrawal, urging informed vaccination decisions.
Read more
(theglobeandmail.com)
Is This Dividend Stock a Buy Now?
Real-time index price for TSX Consumer Staples Capped Index (TTCS), along with buy or sell indicators, analysis, charts, historical performance, news and more
Read more
(indianexpress.com)
UPSC Key | 1st May, 2024 — Covishield, World Economic Outlook, Look Out Circular and more
Exclusive for Subscribers from Monday to Friday: How are Covishield and IMF's World Economic Outlook relevant to the UPSC Exam? What significance do topics like El-Nino and new productive force have for the preliminary and main exams?
Read more
(wionews.com)
AstraZeneca admits in court that its Covid vaccine can ‘in very rare cases, cause TTS’
For the first time since its COVID-19 vaccine was rolled out, AstraZeneca has admitted that it can cause a rare side effect. In legal documents submitted to the United Kingdom High Court, the pharmaceutical giant accepted that its COVID-19 vaccine "can, in very rare cases, cause TTS".
Read more
(wionews.com)
AstraZeneca admits in court that its Covid vaccine can ‘in very rare cases, cause TTS’
For the first time since its COVID-19 vaccine was rolled out, AstraZeneca has admitted that it can cause a rare side effect. In legal documents submitted to the United Kingdom High Court, the pharmaceutical giant accepted that its COVID-19 vaccine "can, in very rare cases, cause TTS".
Read more
(wionews.com)
AstraZeneca admits in court that its Covid vaccine can ‘in very rare cases, cause TTS’
For the first time since its COVID-19 vaccine was rolled out, AstraZeneca has admitted that it can cause a rare side effect. In legal documents submitted to the United Kingdom High Court, the pharmaceutical giant accepted that its COVID-19 vaccine "can, in very rare cases, cause TTS".
Read more